About Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF Accum-1C- USD

XGEN invests in stocks. The fund's major sectors are Health Technology, with 87.50% stocks, and Health Services, with 9.04% of the basket. The assets are mostly located in the North America region.

XGEN top holdings are AbbVie, Inc. and Agilent Technologies, Inc., occupying 4.78% and 4.57% of the portfolio correspondingly.

XGEN assets under management is ‪6.61 M‬ USD. It's risen 0.59% over the last month.

XGEN fund flows account for ‪1.91 M‬ USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

No, XGEN doesn't pay dividends to its holders.

XGEN expense ratio is 0.35% meaning you'd have to pay 0.35% of your investment to help manage the fund.

XGEN follows the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100 Index - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

XGEN invests in stocks.

XGEN price has risen by 1.00% over the last month, and its yearly performance shows a 1.47% increase. See more dynamics on XGEN price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 2.56% over the last month, showed a 11.50% increase in three-month performance and has decreased by −1.40% in a year.